Literature DB >> 33321357

Pregnancy outcome in patients with multiple sclerosis treated with Rituximab: A case-series study.

Maral Seyed Ahadi1, Mohammad Ali Sahraian1, Seyed Mohammad Baghbanian2, Amirreza Azimi1, Vahid Shaygannejad3, Nassim Anjidani4, Seyed Ehsan Mohammadiani Nejad5, Sadegh Izadi6, Nahid Beladi Moghadam7, Hormoz Ayromlou8, Fereshteh Ashtari9, Abolghasem Amiri10, Zahra Niknam11, Farhad Asarzadegan7, Mehrdokht Mazdeh12, Asghar Bayati13, Gholam Ali Yousefi Pour6, Sepideh Yazdanbakhsh1, Abdorreza Naser Moghadasi14.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2020        PMID： 33321357     DOI： 10.1016/j.msard.2020.102667

Source DB:  PubMed          Journal:  Mult Scler Relat Disord        ISSN： 2211-0348            Impact factor:   4.339


× No keyword cloud information.
  2 in total

1.  Pregnancy outcomes in women with pemphigus exposed to rituximab before or during pregnancy.

Authors:  Azin Dehghanimahmoudabadi; Nika Kianfar; Marwa Akhdar; Shayan Dasdar; Kamran Balighi; Hamidreza Mahmoudi; Maryam Daneshpazhooh
Journal:  Int J Womens Dermatol       Date:  2022-07-12

Review 2.  Use of B-Cell-Depleting Therapy in Women of Childbearing Potential With Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder.

Authors:  Alexandra Galati; Thomas McElrath; Riley Bove
Journal:  Neurol Clin Pract       Date:  2022-04
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.